Impaction Grafting of the Femur (IGF)

Author(s):  
Eustathios Kenanidis ◽  
Eleftherios Tsiridis ◽  
Eduardo García-Cimbrelo ◽  
Eduardo García-Rey ◽  
Martin Buttaro ◽  
...  
Keyword(s):  
2013 ◽  
Vol 9 (3) ◽  
pp. 242-246 ◽  
Author(s):  
Johannes Buckup ◽  
Emiliano Alvarez Salinas ◽  
Alejandro Gonzalez Della Valle ◽  
Friedrich Boettner

Orthopedics ◽  
2003 ◽  
Vol 26 (9) ◽  
pp. 941-942
Author(s):  
Ian D Learmonth

2006 ◽  
Vol 452 ◽  
pp. 250-259 ◽  
Author(s):  
Gerjon Hannink ◽  
Per Aspenberg ◽  
B Willem Schreurs ◽  
Pieter Buma

2013 ◽  
Vol 84 (4) ◽  
pp. 371-376 ◽  
Author(s):  
Michael R Whitehouse ◽  
Peter J Dacombe ◽  
Jason C J Webb ◽  
Ashley W Blom

2018 ◽  
Vol 29 (1) ◽  
pp. 26-34
Author(s):  
Ola Belfrage ◽  
Magnus Tägil ◽  
Martin Sundberg ◽  
Uldis Kesteris ◽  
Gunnar Flivik

Background: Bisphosphonates have previously been shown to increase the density of impacted graft bone. In the present study we hypothesise that bisphosphonates also reduce early stem subsidence. We examined the effect of locally applied bisphosphonate to allografts on prosthetic micromotion and bone density in femoral stem revision with impaction grafting. Methods: 37 patients were randomised to either clodronate or saline as local adjunct to the morsellised allograft bone. 24 patients were finally analysed per protocol and evaluated by dual-energy x-ray absorptiometry (DXA) during the first year and with radiostereometric analysis (RSA) for 5 years. Results: There were no significant differences neither in bone density, nor in migratory behaviour between the groups. The femoral stems had subsided 3.6 mm in both groups (p = 0.99) at 5 years and there was no difference as measured over time with mixed models analysis. The clinical outcome was good in both groups. Conclusion: Clodronate as a local addendum to allograft bone in hip revision did not increase bone density or reduce micromotion of the implant.


Sign in / Sign up

Export Citation Format

Share Document